Keyphrases
3D Scaffold
100%
Adult Human Mesenchymal Stem Cells
50%
Aligned Pores
50%
Bioreactor
100%
Biphasic Constructs
50%
Cartilage Matrix
50%
Cell Layer
50%
Cell-based
100%
Chondrogenic
50%
Chondrogenic Differentiation
50%
Collage
50%
Compact Cell
50%
Control Construct
50%
Culture Time
50%
Differentiation Medium
100%
Dual Flow
50%
Engineering Technique
50%
Enthesitis
100%
Extracellular Matrix
50%
Fetal Bovine Serum
50%
Flow Bioreactor
50%
Fluidic System
50%
Fluidics
100%
Functional Matrix
50%
Gene Expression
50%
Hematoxylin-eosin Staining
50%
Hyperelastic
100%
Matrix Formation
50%
Mesenchymal Stem
100%
MTS Assay
50%
PLGA Scaffold
50%
Porous Cavity
50%
Quantitative PCR
50%
Random Pore Model
50%
Regeneration
50%
Serum-free
50%
SOX9 Gene
50%
Specific Marker
50%
Tendon
100%
Tendon Enthesis
100%
Tendon Repair
50%
Tendon-bone Interface
50%
Tenogenic
50%
Tenogenic Differentiation
50%
Tenomodulin
50%
Tissue Culture Plate
50%
Tissue Engineering
50%
INIS
adults
16%
applications
100%
bioreactors
50%
bones
33%
bovine
16%
cartilage
16%
cavities
16%
compacts
16%
comparative evaluations
16%
compartments
16%
control
33%
engineering
16%
eosin
16%
fabrication
100%
fibers
16%
genes
16%
hematoxylin
16%
humans
16%
interfaces
16%
layers
16%
levels
16%
matrices
50%
mimic
16%
pcr
16%
plates
16%
porous materials
16%
production
33%
randomness
16%
regeneration
16%
repair
16%
ruptures
16%
stem cells
100%
surgery
16%
tendons
100%
tissue cultures
16%
tissues
16%
Engineering
Bioreactor
100%
Chondrogenic Differentiation
33%
Fiber Scaffold
33%
Fluidics
100%
Mesenchymal Stem Cell
100%
Porous Cavity
33%
Printed Scaffold
100%
Tissue Regeneration
33%
Biochemistry, Genetics and Molecular Biology
Eosin
50%
Gene Expression
50%
Porosity
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
50%
SOX9
50%
Stem Cell
100%
Tissue Culture
50%
Tissue Regeneration
50%
Upregulation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Eosin
100%
Haematoxylin
100%
Recurrent Disease
100%
Material Science
Fluidics
100%
Gene Expression
33%
Quantitative Reverse Transcription Polymerase Chain Reaction
33%
Stem Cell
100%